Don’t wait for the future – be proactive for your patients with T2D now!

Boehringer Ingelheim and Eli Lilly and Company |
Tuesday

Chair: John Buse (USA)

Faculty:

  • David Cherney (CAN)
  • Xavier Cos (ESP)
  • Shelley Zieroth (CAN)